The effect of periconceptional multivitamin supplementation on postnatal development was studied in a randomised controlled trial comparing the use of a multivitamin tablet (Elevit Pronatal) with a tablet containing trace elements as part of the Hungarian Optimal Family Planning Programme. Of 4122 liveborn infants, 3356 were examined after the eighth month of life and medical records were obtained for a further 357; thus the total number of infants evaluated was 3713 (90/1%). The mortality was not significantly different between the groups receiving the multivitamins (9-6/1000) and trace elements (7.1/1000). There was no significant difference in the rates of serious or chronic disorders between the study groups except for atopic dermatitis, which was reported more often in the group receiving multivitamins (15 v four cases). Somatic development (body weight, body length, and head circumference) did not show a significant difference between the two groups. Mental and behavioural development was also similar in the two groups.
Periconceptional supplementation with a multivitamin formulation, including folic acidl 2 or with folic acid alone34 can reduce the recurrence of neural tube defects. The Hungarian randomised controlled trial of periconceptional multivitamin (including 0-8 mg folic acid) supplementation indicated (a) a significant reduction of the first occurrence of neural tube defects,5 (b) a significantly lower rate of major congenital abnormalities not completely explained by the significant reduction in neural tube defects,6 (c) no significant effect on pregnancy outcomes (different types of fetal death, proportion of low birthweight newborns and preterm births) (A E Czeizel, I Dudas, J Metneki, unpublished data), (d) a low incidence of adverse reactions in the mothers (allergic skin exanthemata, constipation, diarrhoea),7 and (e) a significantly lower rate of morning sickness (nausea and vomiting) in early pregnancy.7 This primary prevention of neural tube defects has great public health importance as it is a better alternative to prenatal diagnosis and selective abortion, in addition to the obvious decrease in medical costs. Because of the expected widespread recommendation and the use of this method, its effects should be examined carefully, including those on postnatal somatic and mental development. In one UK study, 96 children aged 2-5 years and 91 children aged 7-10 years were assessed clinically for somatic and mentalbehavioural development after periconceptional supplementation with Pregnavit Forte F.8 This study group had no appropriate control, however. At age 7-10 years, the girls were considerably taller than expected. Health, auditory, visual, and developmental status were no different from the general population. None showed a major behaviour disorder but worries, fussiness, and fearfulness were over represented.
The objective of the work reported here is to examine the developmental effects of periconceptional multivitamin supplementation in the children born during the Hungarian randomised controlled trial. [5] [6] [7] Subjects and methods The Hungarian Optimal Family Planning Programme (HOFPP) provides periconceptional care for women and their partners. The randomised controlled trial of periconceptional multivitamins as opposed to trace element supplementation was incorporated into the HOFPP. The criteria for participation and the use of full, partial, or no supplementation, the method of randomisation and tablet supply for at least one month before and two months after conception and the components of the 'multivitamin' (Elevit Pronatal) including 0-8 mg folic acid and 'trace elements' have been presented elsewhere.5 6 Women were referred to prenatal care clinics at the 12th week of pregnancy. They were asked to send us their HOFPP certificate about their pregnancy outcome and to visit us with their infants after they were 8 months old.
FIRST FOLLOW UP
Parents of infants born within the HOFPP were reminded by telephone or letter to attend for an examination of their infants at about the eighth month of life. After reviewing medical records about previously diagnosed congenital anomalies and diseases, treatments, and operations, the examination included (a) a determination of somatic growth by anthropometric measurements, (b) a clinical examination, and (c) the assessment of mental and behavioural development. These examinations were performed blind by an anthropometrist, two paediatricians, and two psychologists. Mental development was measured by the Popper-Szondy functional development test9 10 Czeizel, Dob6 tSpina bifida cystica, congenital hydrocephalus, transposition of great vessels, left heart hypoplasia. 
6-0-6-9 Mean (95% confidence 9-96 (9-88 to 9-34 (9-26 to 9-65 (9-59 to 10-01 (9-93 to 9-30 (9-22 to 9-67 (9-61 to interval)
10-04) 9-42) 9-71) 10-09) 9-38) 9-73) infants. In addition, eczema, asthma, and wheezy bronchitis, which are closely related, also showed a significantly higher rate in infants born from mothers supplemented with multivitamins in the periconceptional period. These unexpected findings may be a chance effect; however, they need further study. There was no difference in the postnatal somatic development of infants between the multivitamin and trace element groups. In the UK study at age 7-10 years, girls were taller. 8 In the Hungarian study, however, girls at about the age of 11 months did not have a greater body length.
The mental and behavioural tests did not show any significant difference in the early postnatal development of infants in the multivitamin and trace element groups. These figures considerably exceed the population average, however, which may be due to the social selection of the HOFPP participants and the optimum periconceptional, prenatal, and postnatal care of their offspring. Our study was not appropriate in confirming or disproving the findings of the UK study -that is, the over representation of worries and anxiety among children at age 7-10 years.8 It is, of course, difficult to study tlese behavioural traits at 11 months of age. (n the other hand, it is possible that the findings were related to maternal anxiety caused by previous pregnancies with neural tube defects.
In conclusion, periconceptional multivitamin supplementation did not appear to affect the postnatal somatic and mental development of infants at the age of 11 months. Data at this early age have poor predictive power for subsequent development, however. Further study of these children is in progress.
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